Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corp (AMWL) is a leading telehealth platform enabling digital care solutions across healthcare ecosystems. This page serves as the definitive source for verified news and official announcements from the company, providing stakeholders with timely insights into strategic developments.
Access comprehensive updates including earnings reports, technology innovations, partnership announcements, and regulatory milestones. Investors and industry observers can track AMWL's progress in advancing hybrid care models and expanding its digital health infrastructure.
All content is curated to ensure relevance to AMWL's operations in virtual care delivery, platform enhancements, and collaborations with healthcare providers. Bookmark this page for efficient monitoring of the company's evolving role in shaping accessible, technology-driven healthcare solutions.
Amwell (NYSE: AMWL) announced the appointment of Robert Webb to its Board of Directors, effective immediately. With over 30 years of experience in healthcare technology, Mr. Webb aims to enhance Amwell's market position and growth trajectory. His previous roles include CEO of Optum's consumer network and President of UnitedHealth Group Ventures. Amwell focuses on digital healthcare enablement, connecting various stakeholders to improve care accessibility and quality. The company supports over 2,000 hospitals and 55 health plan partners, impacting over 80 million lives.
BOSTON--(BUSINESS WIRE)--Amwell (NYSE: AMWL), a digital healthcare leader, announced key participation in upcoming investor conferences. On November 10, 2022, CEO Dr. Ido Schoenberg and CFO Bob Shepardson will attend the Credit Suisse Healthcare Conference, hosting a fireside chat at 8:30 a.m. PT. Shepardson will also engage in meetings at the Needham & Co. Virtual Health Tech One-on-One Conference on November 15 and at BTIG's Virtual Healthcare Day on November 21. They will meet investors again on November 30 at the Piper Sandler Healthcare Conference in New York City.
Amwell (NYSE: AMWL) will report third-quarter operating results for the period ending September 30, 2022, on November 7, 2022. Following the earnings release, management will host a live conference call at 5:00 PM ET to discuss the results and provide a business update. Investors can access the webcast on the company's website or by calling U.S. and international numbers. Amwell is a leading digital healthcare platform, enabling improved access to affordable care, serving over 2,000 hospitals and covering more than 80 million lives.
Amwell (NYSE: AMWL) announces key executive appointments, bringing a combined 40 years of experience to its leadership team. Vaughn Paunovich joins as Executive Vice President of Enterprise Platforms, focusing on technological delivery and innovation for the Converge platform. Matthew McAllister takes on the role of Chief Product Officer, overseeing product management and design. CEO Roy Schoenberg emphasized the importance of these roles amidst the digital transformation in healthcare, positioning Amwell as a partner in meeting customer needs for integrated technological solutions.
Amwell (NYSE: AMWL) has launched its inaugural Environmental, Social and Governance (ESG) Framework, emphasizing its commitment to sustainable growth. The Framework focuses on three pillars: People, promoting talent development and wellbeing; Products, enhancing digital care delivery through its Converge™ platform; and Operations, ensuring high ethical standards and robust data privacy. CEO Dr. Ido Schoenberg stated this marks a significant milestone in Amwell's ESG journey, with plans for transparency and progress updates in the future.
BOSTON--(BUSINESS WIRE)--Amwell (NYSE: AMWL), a digital care delivery leader, will have management participate in upcoming investor conferences. On September 8, 2022, Dr. Ido Schoenberg and CFO Bob Shepardson will engage in a fireside chat at the Wells Fargo Healthcare Conference at 11 a.m. ET. Subsequently, on September 13, 2022, they will attend the Morgan Stanley 20th Annual Global Healthcare Conference in New York City at 1:30 PM ET. Webcasts will be available at investors.amwell.com.
On August 8, 2022, Amwell (NYSE: AMWL) received the 2022 North America Customer Value Leadership Award from Frost & Sullivan for its Converge platform. This recognition highlights Amwell’s commitment to improving digital healthcare delivery through comprehensive technology solutions for healthcare organizations. The Converge platform aims to enhance operational efficiency, improve patient-provider interactions, and address staffing shortages. The integration of AI through partnerships, including with Google Cloud, further elevates its service offerings, ensuring flexible and effective digital care.
Amwell (NYSE: AMWL) reported its Q2 2022 financial results, achieving $64.5 million in total revenue, a 7% increase from Q2 2021. Subscription revenue rose 10% to $29.6 million, while AMG visit revenue grew 8% to $29.7 million. Gross margin was reported at 43.4%, and adjusted EBITDA improved to ($42.8) million. Active providers surged 46% to 103,500, with total visits increasing 19% to 1.5 million. Amwell expects 2022 revenue between $275 and $285 million.
Amwell (NYSE: AMWL), a leader in digital care delivery, will report its second quarter results for the period ending June 30, 2022, on Thursday, August 4, 2022. The management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the results and provide updates. Investors can access the webcast on the Amwell website or listen via phone. Amwell connects providers, insurers, and patients to enhance access to affordable healthcare, serving over 2,000 hospitals and 55 health plans worldwide.
Amwell (NYSE: AMWL) has appointed Dr. Carrie Nelson as its new Chief Medical Officer, bringing over 28 years of experience in Family Medicine and population health. Dr. Nelson aims to enhance clinical and operational outcomes for provider and payer organizations through Amwell's digital care delivery platform, Converge™. Previously, she served as Senior Vice President and CMO at Advocate Aurora Health. COO Kurt Knight emphasized her clinical background will be instrumental in advancing Amwell's sales, implementation, and quality metrics within the hybrid healthcare landscape.
